All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

3,685

Reset

3,685 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • PirmitegravirPhase 21 trial

    ST Pharm Co., Ltd. · HIV-1-infection

  • PKN605Phase 21 trial

    Novartis · Atrial Fibrillation

  • PL8177Active study medicationPhase 21 trial

    Palatin Technologies, Inc · Ulcerative Colitis, Ulcerative Colitis Acute, Ulcerative

  • PLH-2301Phase 21 trial

    Pluto Inc. · Sarcopenia in Elderly

  • PlixorafenibFORE8394, PLX-8394Phase 21 trial

    Fore Biotherapeutics · Cancer Harboring BRAF Alterations, HGG, LGG

  • PLL001Phase 21 trial

    PLL TX AUSTRALIA PTY LTD · Amyotrophic Lateral Sclerosis, ALS

  • PM1009Phase 21 trial

    Biotheus Inc. · HCC, Liver Cancer

  • PM359Phase 21 trial

    Prime Medicine, Inc. · Chronic Granulomatous Disease, Granulomatous Disease, Chronic

  • PM577aPhase 21 trial

    Prime Medicine, Inc. · Wilson Disease, Wilson's Disease, Wilsons Disease

  • PM647aPhase 21 trial

    Prime Medicine, Inc. · Alpha-1 Antitrypsin Deficiency, Alpha-1 Antitrypsin Deficiency-associated Lung Disease, Alpha-1 Antitrypsin Deficiency (AATD)

  • PMD-026Phase 21 trial

    Phoenix Molecular Designs · Metastatic Breast Cancer

  • PN-101Phase 21 trial

    Paean Biotechnology Inc. · Polymyositis, Dermatomyositis

  • PN20Phase 21 trial

    Chongqing Peg-Bio Biopharm Co., Ltd. · Thrombocytopenia Associated With Chronic Liver Disease

  • PP353Phase 21 trial

    Persica Pharmaceuticals Ltd · Chronic Low-back Pain

  • PPV-06Phase 21 trial

    Peptinov SAS · Osteoarthritis, Knee

  • TransThera Sciences (Nanjing), Inc. · Prostate Cancer (CRPC)

  • PRGN-2009Phase 21 trial

    Precigen, Inc · Cervical Cancer, HPV-Related Carcinoma, HPV-Related Malignancy

  • PRGN-2012Phase 21 trial

    Precigen, Inc · Recurrent Respiratory Papillomatosis, Papillomavirus Infections, Papillomaviridae

  • PRI-002ContraloidPhase 21 trial

    PRInnovation GmbH · Mild Cognitive Impairment Due to Alzheimer's Disease, Alzheimer's Disease, Early Onset

  • PRO-1562Phase 21 trial

    Progentos Therapeutics · Multiple Sclerosis

  • PRO-203Phase 21 trial

    Prolium Bioscience, Inc · Healthy Volunteers, Systemic Sclerosis (SSc), Scleroderma, Systemic

  • PRT-064040Phase 21 trial

    Sichuan Purity Pharmaceutical Technology Co., Ltd. · Migraine

  • PRT042Phase 21 trial

    Sichuan Purity Pharmaceutical Technology Co., Ltd. · Major Depressive Disorder (MDD

  • PRTX007Phase 21 trial

    Primmune Therapeutics, Inc. · Melanoma Stage III

  • PRX-115Phase 21 trial

    Protalix · Gout

  • PST-611Phase 21 trial

    Eyevensys · Geographic Atrophy, Age - Related Macular Degeneration (AMD)

  • PTC844Phase 21 trial

    PTC Therapeutics · Rheumatoid Arthritis

  • PTP-001Phase 21 trial

    Bioventus LLC · Osteoarthritis, Knee

  • PTT-4256Phase 21 trial

    Pathios Therapeutics Pty Ltd · Advanced Solid Tumor

  • PTT-621Phase 21 trial

    Pyrotech Therapeutics, Inc. · Ulcerative Colitis (UC)

  • PTT-936Phase 21 trial

    Pyrotech Therapeutics, Inc. · Locally Advanced or Metastatic Solid Tumors

  • PTX-100Phase 21 trial

    Prescient Therapeutics, Ltd. · CTCL

  • PUL-042Phase 21 trial

    Pulmotect, Inc. · Hematologic Malignancies, Hematopoietic Stem Cell Transplant (HSCT)

  • PVX-108Phase 21 trial

    Aravax Pty Ltd · Peanut Allergy, Peanut Hypersensitivity, Peanut-Induced Anaphylaxis

  • PXS-4728Phase 21 trial

    Syntara · REM Sleep Behavior Disorder

  • PYC-001Phase 21 trial

    PYC Therapeutics · OPA1 Gene Mutation, Autosomal Dominant Optic Atrophy, Hereditary Optic Atrophies

  • PYX-201Phase 21 trial

    Pyxis Oncology, Inc · Advanced Solid Tumors

  • Q702Phase 21 trial

    Qurient Co., Ltd. · Esophageal Cancer, Gastric Cancer, Hepatocellular Cancer

  • QD202Phase 21 trial

    Shanghai QuietD Biotechnology Co., Ltd. · Acute Ischemic Stroke

  • QEL-001HLA-A2 CAR-TregPhase 21 trial

    Quell Therapeutics Limited · Rejection; Transplant, Liver, Liver Failure, Liver Diseases

  • QEL-005Phase 21 trial

    Quell Therapeutics Limited · Diffuse Cutaneous Systemic Sclerosis, Rheumatoid Arthritis (RA), Systemic Sclerosis (SSc)

  • QHRD106MiddlePhase 21 trial

    Changzhou Qianhong Bio-pharma Co., Ltd. · Acute Ischemic Stroke

  • QL1203Phase 21 trial

    Qilu Pharmaceutical Co., Ltd. · Solid Tumor

  • QL2401Phase 21 trial

    Qilu Pharmaceutical Co., Ltd. · Metabolic Dysfunction-associated Steatohepatitis (MASH)

  • QLC1101Phase 21 trial

    Qilu Pharmaceutical Co., Ltd. · Solid Tumor

  • QLC5513Phase 21 trial

    Qilu Pharmaceutical Co., Ltd. · Metastatic Solid Tumors

  • QLF31907Phase 21 trial

    Qilu Pharmaceutical Co., Ltd. · Advanced Malignant Neoplasm

  • QLP2117Phase 21 trial

    Qilu Pharmaceutical Co., Ltd. · Advanced Solid Tumor

  • QLS1304Phase 21 trial

    Qilu Pharmaceutical Co., Ltd. · Advanced ER+/HER2- Breast Cancer

  • QLS1410Phase 21 trial

    Qilu Pharmaceutical Co., Ltd. · Primary Aldosteronism

NewerPage 65 of 74Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.